The expanding spectrum of rare monogenic autoinflammatory diseases.
Résumé
: Monogenic autoinflammatory diseases are a group of hereditary disorders characterized by a clinical and biological inflammatory syndrome in which there is little or no evidence of autoimmunity. The discovery of the first causative gene in 1997 was rapidly followed by the identification of many others from the same group. The mutated proteins can be directly or indirectly involved in the regulation of inflammation. The available literature includes numerous reviews, which address the principle diseases, but we wanted to focus on the most recent rare syndromes. A comprehensive review is thus provided, including taxonomic, genetic, and epidemiological data, along with characteristics defining positive and differential diagnoses and treatment. We believe that this update will assist physicians in correctly naming their patient's illness. This is an essential step for the effective and targeted management of an orphan disease.
Mots clés
Autoinflammatory diseases
Histiocytosis and lymphadenopathy syndrome (H Syndrome)
NLRP12 Associated Periodic Syndrome (NAPS12)
Deficiency of Interleukin 1 Receptor Antagonist (DIRA)
Deficiency of interleukin 36 receptor antagonist (DITRA)
Pityriasis rubra pilaris (PRP)
Disseminated Superficial Actinic Porokeratosis (DSAP)
Autoinflammation LipoDystrophy and Dermatosis syndrome (ALDD)
Domaines
Génétique
Fichier principal
1750-1172-8-162.pdf (223.54 Ko)
Télécharger le fichier
1750-1172-8-162.xml (102.02 Ko)
Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Format : Autre
Loading...